Nylim US LG Ca R&D LD ETF-UiLRNDETF
13F holders, Q2 2025 (June 30)5holders +1
2new positions
1sold out
$36.09avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Nylim US LG Ca R&D LD ETF-Ui (LRND) in their 13F filings, up 1 from Q1 2025. 2 opened new positions and 1 sold out. The largest holders were New York Life Investment Management LLC ($6.9M), GTS Securities LLC ($593K) and UBS Group AG ($2K).
- Company
- Nylim US LG Ca R&D LD ETF-Ui
- Filed as
- NEW YORK LIFE INVESTMENTS ET (Q2 2025)
- CUSIP
- 45409B263
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $2K |
| Exits | 1 | $45K |
All 13F filers, Q1 2025 → Q2 2025: 70 shares bought and 2,353 shares sold, net −2,283 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| New York Life Investment Management LLC | 0.06% | No change | 190,000 | $6.9M |
| GTS Securities LLC | 0.03% | Reduce -5.6% | 16,417 | $593K |
| UBS Group AG | 0.00% | Add +11.3% | 69 | $2K |
| Osaic Holdings, Inc. | 0.00% | New | 62 | $2K |
| Morgan Stanley | 0.00% | New | 1 | $46 |
"% of holder's portfolio" is LRND's weight in each manager's 13F, not the share of Nylim US LG Ca R&D LD ETF-Ui the manager owns.